Network origin in Rodolfo J. Chaparro first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
Albert Einstein College of Medicine, Inc.
8
| College/University | Other Consumer Services | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rodolfo J. Chaparro via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| THE ARENA GROUP HOLDINGS, INC. | Internet Software/Services | Chief Executive Officer Director of Finance/CFO | |
| PRESSURE BIOSCIENCES, INC. | Medical Specialties | Director of Finance/CFO | |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Investment Banks/Brokers | Chief Executive Officer Founder Analyst-Equity Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| QUEST PHARMATECH INC. | Miscellaneous Commercial Services | Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
| University of Virginia | College/University | Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree | |
| Colorado State University | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| The University of Colorado | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Georgia | College/University | Doctorate Degree Doctorate Degree | |
| University of Louisville | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Corporate Officer/Principal Undergraduate Degree | |
PTV Sciences LP
 PTV Sciences LP Investment ManagersFinance PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas. | Investment Managers | Corporate Officer/Principal | |
| Technion-Israel Institute of Technology | College/University | Undergraduate Degree Graduate Degree | |
| Georgetown University | College/University | Graduate Degree | |
Carnegie Institution of Washington
 Carnegie Institution of Washington Miscellaneous Commercial ServicesCommercial Services Carnegie Institution of Washington is engaged in providing technical and scientific research services. The company was founded by Andrew Carnegie in 1895 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Long Island Jewish Medical Center
 Long Island Jewish Medical Center Hospital/Nursing ManagementHealth Services Long Island Jewish Medical Center provides health care services. Its Schneider Children's Hospital gives treatment to kids it contains more than 150 beds and The Zucker Hillside Hospital, a psychiatric hospital that contains 220 beds. The company is headquartered in New Hyde Park, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Texas Southwestern Medical Center | College/University | Corporate Officer/Principal | |
Evercore Group LLC
 Evercore Group LLC Investment Banks/BrokersFinance Evercore Group LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1995 and is a subsidiary of Evercore BD Investco LLC, which is owned by Evercore, Inc. (NYSE: EVR). Evercore Group delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors. | Investment Banks/Brokers | Analyst-Equity | |
| George Washington University Law School | College/University | Graduate Degree Graduate Degree | |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MDB CAPITAL HOLDINGS, LLC | Chief Executive Officer Director/Board Member | ||
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Mount Sinai Medical Center, Inc.
 The Mount Sinai Medical Center, Inc. Hospital/Nursing ManagementHealth Services The Mount Sinai Medical Center, Inc. operates charitable teaching hospitals. The non-profit company is based in New York, NY. The CEO of the company is Gino Santorio. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Dartmouth Medical School | College/University | Doctorate Degree | |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Founder | |
Dose Therapeutics, Inc.
 Dose Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan. | Miscellaneous Commercial Services | Founder | |
| 23ANDME HOLDING CO. | Biotechnology | Corporate Officer/Principal |
Statistics
International
| United States | 43 |
| Canada | 3 |
| United Kingdom | 2 |
| Israel | 2 |
| Belgium | 2 |
Sectoral
| Consumer Services | 17 |
| Health Technology | 15 |
| Commercial Services | 9 |
| Finance | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 106 |
| Corporate Officer/Principal | 66 |
| Independent Dir/Board Member | 37 |
| Undergraduate Degree | 24 |
| Director of Finance/CFO | 20 |
Most connected contacts
| Insiders | |
|---|---|
| Tamar Howson | 41 |
| Peter Kiener | 25 |
| Fred Driscoll | 21 |
| Frank Morich | 21 |
| Steven McKnight | 16 |
| Anthony DiGiandomenico | 14 |
| Aaron Fletcher | 12 |
| Marco Pappagallo | 11 |
| Angela Rossetti | 11 |
| Cameron Gray | 11 |
| Joseph Luis Damasio | 10 |
| Daniel Passeri | 9 |
| Colin Sandercock | 8 |
| Kenneth J. Pienta | 8 |
| Chris Marlett | 8 |
- Stock Market
- Insiders
- Rodolfo J. Chaparro
- Company connections
